Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostatic Neoplasms × varlilumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Melanoma 1 Margins of Excision 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Carcinoma, Renal Cell 1 Astrocytoma 1

Interventions

Docetaxel 39 enzalutamide 25 Prednisone 21 Abiraterone Acetate 20 Magnetic Resonance Spectroscopy 17 bicalutamide 13 Radiotherapy 13 Cyclophosphamide 13 pembrolizumab 12 darolutamide 11 abiraterone 11 Leuprolide 11 Goserelin 11 Ipilimumab 10 apalutamide 9 Specimen Handling 9 Radiosurgery 9 Radiation 9 Biopsy 9 olaparib 8 Paclitaxel 8 Injections 8 Radiotherapy, Intensity-Modulated 7 Carboplatin 7 sargramostim 6 fludarabine 6 cabazitaxel 6 Pluvicto 6 Cisplatin 6 radium Ra 223 dichloride 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02284971 2018-05-17

Prostate-04

University of Virginia

Phase 1 Terminated

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡